136 related articles for article (PubMed ID: 7505225)
1. Prostatic spiral versus prostatic urolume wallstent for urinary retention due to benign prostatic hyperplasia. A long-term comparative study.
Guazzoni G; Montorsi F; Bergamaschi F; Consonni P; Bellinzoni P; Rigatti P
Eur Urol; 1993; 24(3):332-6. PubMed ID: 7505225
[TBL] [Abstract][Full Text] [Related]
2. Long term experience with the prostatic spiral for urinary retention due to benign prostatic hyperplasia.
Guazzoni G; Montorsi F; Colombo R; Di Girolamo V; Da Pozzo L; Rigatti P
Scand J Urol Nephrol; 1991; 25(1):21-4. PubMed ID: 1710824
[TBL] [Abstract][Full Text] [Related]
3. The UroLume stent in the management of benign prostatic hyperplasia.
Milroy E; Chapple CR
J Urol; 1993 Nov; 150(5 Pt 2):1630-5. PubMed ID: 7692100
[TBL] [Abstract][Full Text] [Related]
4. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia.
Masood S; Djaladat H; Kouriefs C; Keen M; Palmer JH
BJU Int; 2004 Dec; 94(9):1271-4. PubMed ID: 15610103
[TBL] [Abstract][Full Text] [Related]
5. [Long-term results and indications of intraurethral stents in elderly patients with prostatic hypertrophy complaining of urinary retention].
Takeda M; Takahashi H; Tsutsui T; Go H; Hatano A; Sato S; Sasagawa T; Sakata Y; Hiraiwa M; Ando T
Hinyokika Kiyo; 1993 Nov; 39(11):1011-5. PubMed ID: 7505521
[TBL] [Abstract][Full Text] [Related]
6. A comparison of transrectal hyperthermia, transurethral thermotherapy, urolume wallstent, and prostatic spiral for benign prostatic hyperplasia patients at poor operative risk.
Montorsi F; Guazzoni G; Bergamaschi F; Consonni P; Galli L; Rigatti P
Prostate; 1994; 24(3):156-61. PubMed ID: 7509486
[TBL] [Abstract][Full Text] [Related]
7. The biodegradable self-reinforced poly-DL-lactic acid spiral stent compared with a suprapubic catheter in the treatment of post-operative urinary retention after visual laser ablation of the prostate.
Pétas A; Talja M; Tammela TL; Taari K; Välimaa T; Törmälä P
Br J Urol; 1997 Sep; 80(3):439-43. PubMed ID: 9313664
[TBL] [Abstract][Full Text] [Related]
8. The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group.
Oesterling JE; Kaplan SA; Epstein HB; Defalco AJ; Reddy PK; Chancellor MB
Urology; 1994 Sep; 44(3):353-62. PubMed ID: 7521091
[TBL] [Abstract][Full Text] [Related]
9. Prostatic UroLume Wallstent for benign prostatic hyperplasia patients at poor operative risk: clinical, uroflowmetric and ultrasonographic patterns.
Guazzoni G; Bergamaschi F; Montorsi F; Consonni P; Galli L; Matozzo V; Rigatti P
J Urol; 1993 Nov; 150(5 Pt 2):1641-6; discussion 1646-7. PubMed ID: 7692102
[TBL] [Abstract][Full Text] [Related]
10. The titanium intraprostatic stent: the United States experience.
Kaplan SA; Merrill DC; Mosely WG; Benson RC; Chiou RK; Fuselier HA; Parra RO
J Urol; 1993 Nov; 150(5 Pt 2):1624-9. PubMed ID: 7692099
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study.
Kotsar A; Isotalo T; Juuti H; Mikkonen J; Leppiniemi J; Hänninen V; Kellomäki M; Talja M; Tammela TL
BJU Int; 2009 Mar; 103(5):626-9. PubMed ID: 18990149
[TBL] [Abstract][Full Text] [Related]
12. The use of intraurethral prostatic spiral in high risk patients for surgery with benign prostatic hyperplasia.
Ozgür GK; Sivrikaya A; Bilen R; Biberoğlu K; Gümele HR
Int Urol Nephrol; 1993; 25(1):65-70. PubMed ID: 7685746
[TBL] [Abstract][Full Text] [Related]
13. The use of wallstents in patients with benign prostatic hyperplasia.
Guazzoni G; Montorsi F; Rigatti P
Arch Esp Urol; 1994 Nov; 47(9):927-31. PubMed ID: 7530950
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia.
Carnevale FC; da Motta-Leal-Filho JM; Antunes AA; Baroni RH; Marcelino AS; Cerri LM; Yoshinaga EM; Cerri GG; Srougi M
J Vasc Interv Radiol; 2013 Apr; 24(4):535-42. PubMed ID: 23434084
[TBL] [Abstract][Full Text] [Related]
15. A modified prostatic UroLume Wallstent for healthy patients with symptomatic benign prostatic hyperplasia: a European Multicenter Study.
Guazzoni G; Montorsi F; Coulange C; Milroy E; Pansadoro V; Rubben H; Sarramon JP; Williams G
Urology; 1994 Sep; 44(3):364-70. PubMed ID: 7521092
[TBL] [Abstract][Full Text] [Related]
16. Prostatic UroLume Wallstent for urinary retention due to advanced prostate cancer: a 1-year followup study.
Guazzoni G; Montorsi F; Bergamaschi F; Consonni P; Rigatti P
J Urol; 1994 Nov; 152(5 Pt 1):1530-2. PubMed ID: 7933192
[TBL] [Abstract][Full Text] [Related]
17. A good alternative to indwelling catheter owing to benign prostate hyperplasia in elderly: Memotherm prostatic stent.
Bozkurt IH; Yalcinkaya F; Sertcelik MN; Zengin K; Ekici M; Yigitbasi O
Urology; 2013 Nov; 82(5):1004-7. PubMed ID: 23992964
[TBL] [Abstract][Full Text] [Related]
18. [Role of urodynamics in implantation of prostatic stents].
Comeri G; Conti G; Cretarola E; Furgoni P; Gianneo E
Arch Ital Urol Androl; 1995 Feb; 67(1):81-5. PubMed ID: 7538397
[TBL] [Abstract][Full Text] [Related]
19. [Urethral stent (Memotherm) for the treatment of benign prostatic hyperplasia].
Noda Y; Ujike T; Oka D; Takada S; Fujimoto N; Koide T
Hinyokika Kiyo; 2003 Nov; 49(11):645-7. PubMed ID: 14719451
[TBL] [Abstract][Full Text] [Related]
20. Experience with a new intraurethral stent for high-risk patients with benign prostatic hypertrophy.
Fuse H; Okumura A; Sakamoto M; Katayama T
Int Urol Nephrol; 1993; 25(4):369-74. PubMed ID: 7506240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
